HSA — authorised 14 September 2018
- Marketing authorisation holder: TEVA PHARMS USA
- Status: likely_approved
HSA authorised Ajovy on 14 September 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 14 September 2018.
TEVA PHARMS USA holds the Singaporean marketing authorisation.